Blackheads. Spots. Redness. The dark marks they leave behind.
Four different problems, and most people buy something different for each one. There’s a single ingredient that works on all four — and it’s probably the most useful thing in skincare that nobody can quite explain.
It’s azelaic acid. And if you’ve already tried it and thought it did nothing, stay with me, because the version you bought matters more than almost anyone tells you.
What azelaic acid actually is
It’s a dicarboxylic acid that occurs naturally in grains — wheat, rye and barley — and it turns up in small amounts in the human body as a normal by-product of fat metabolism. Not exotic, not new, and used by dermatologists for decades.
Its skincare career started somewhere unexpected. Researchers studying the pale patches left by a fungal skin condition went looking for what the yeast involved was producing that seemed to switch pigment off. What they isolated was azelaic acid — and in the lab it inhibited tyrosinase, one of the key enzymes in making melanin. That’s the finding that led to it being developed for pigmentation in the first place.
The four jobs
Most ingredients do one thing. Laboratory research points to azelaic acid working on four fronts at once, which is genuinely unusual and is the real reason it gets recommended so often.
- Blackheads and congestion. It helps normalise the keratin lining your pores, so the plugs that become blackheads form less readily. This is the one people notice first, usually on the nose and chin.
- Spots. It works against acne bacteria — by a physical route rather than as an antibiotic, which is why resistance isn’t expected to develop.
- Redness. It calms. This is where its strongest comparative evidence sits, which surprises most people.
- Post-acne marks. It slows pigment production, so the brown marks left behind fade faster than they would on their own.
One ingredient covering spots, the marks spots leave, and the redness around them. That’s rare, and it’s the whole reason it’s worth understanding properly.
Worth saying clearly: those four mechanisms come from laboratory and cell-culture research. They’re how scientists think it works, not a promise about what a bottle will do to your face.
So why did yours do nothing?
Because the bottle decides, not the ingredient.
Azelaic acid dissolves in almost nothing. Its water solubility is roughly 0.24g per 100ml — and products are built at ten to twenty times that. It’s awkward in cosmetic oils too. This is a genuinely difficult ingredient to formulate, and brands have three ways round it:
| Route | What it means | The trade-off |
|---|---|---|
| Suspend it | Undissolved crystals held in a gel or silicone base at low pH | Can feel gritty; famously pills under sunscreen and make-up |
| Neutralise it | Add a base so it dissolves as a salt, usually at a higher pH | Much nicer texture — but it’s no longer the free-acid form the clinical trials used |
| Use a derivative | A different, water-soluble molecule built from azelaic acid | Elegant — but it’s a different ingredient with its own, thinner evidence |
Then there’s what’s sitting next to it, which matters just as much. Tea tree pulls a formula towards oily, breakout-prone skin. Centella pulls it towards red, reactive skin. Put it in a moisturiser and it becomes a daily step; put it with a BHA in a small tube and it becomes a spot treatment.
Same active. Completely different products. On the five azelaic products we stock, the acid sits 2nd, 2nd, 4th and 6th in the ingredient lists. Those aren’t versions of one thing — they’re four different jobs.
Which one is actually yours?
Blackheads, oil, active breakouts the nose-and-chin one
PURITO Azelaic Acid 10 Kojic Tea Tree Serum · 30ml
- Azelaic acid sits second in the ingredient list — the highest position of any of ours
- Paired with tea tree leaf water and oil, kojic acid and niacinamide, so the whole formula points at oil and congestion
- A serum, so it goes under a moisturiser
Redness, reactive skin, or new to actives the gentlest way in
NINE LESS A-Control Azelaic Acid Cream · 50ml
- A moisturiser that happens to contain azelaic acid, alongside panthenol, snail secretion filtrate, lactic acid and centella
- The acid sits fourth, after the silicones — a gentler position, and that’s the point
- With centella and panthenol in the mix, it’s the calmer choice for skin that flares easily
- If actives usually don’t agree with you, start here
One stubborn patch, not your whole face new in
MARY&MAY Spicule Azelaic PDRN Spot Cream · 15g
- 2% azelaic acid with 5% niacinamide, salicylic acid, PDRN, panthenol and Ceramide NP
- Also contains sponge-derived micro spicules, which physically exfoliate as you press it in
- Targeted — for the cluster along the jaw that never quite goes. One or two nights a week
How to use it — this matters as much as which one
- One at a time. These are different routes to the same ingredient, not layers. Stacking them buys irritation, not results.
- Give it 8–12 weeks. Marks and redness are slow. Most people stop at week three and conclude it didn’t work.
- Follow the bottle, not the internet. Some of these are twice daily. Some start at twice a week. That difference is the formula talking, and it’s not a contradiction.
- Buffer it — but how depends on the format. The serums go under a moisturiser, always. The Nine Less cream is your moisturiser step, so buffer underneath it instead — a calming toner or a centella serum. The spot cream is targeted, so carry on with your usual moisturiser everywhere else.
- SPF every morning. Non-negotiable if the marks are what you’re after — UV drives more pigment into a mark that already has too much, and you’ll undo the work without it.
A pairing that works well for most people starting out: a centella serum or a panthenol-rich cream alongside whichever azelaic product you’ve chosen. Dry, tight skin is the single most common reason people abandon this ingredient, and it’s almost always preventable.
What not to layer it with
Not on the same night as a retinoid, an AHA or a separate BHA when you’re starting out — alternate nights instead. This matters most with the Mary&May, which already carries salicylic acid alongside the spicules, so it’s doing two kinds of exfoliation on its own.
Three things almost everyone gets wrong
This is the part that makes shopping for azelaic acid so confusing, and it’s worth knowing before you spend anything.
Myth: “10% is the legal limit for skincare”
Not true. Azelaic acid doesn’t appear in Annex III — the restricted substances list — of the UK and EU cosmetics regulation. There’s no legal concentration cap, and no dedicated safety-committee opinion setting one, as of August 2026.
What draws the line between a cosmetic and a medicine in the UK is the claims a product makes, not the percentage. A UK brand legally sells a 15% azelaic serum as an ordinary cosmetic right now. The 10% convention comes from the US market and is industry habit, not law.
Myth: “A cosmetic serum works like the prescription”
Nearly all the strong clinical evidence for azelaic acid comes from trials at 15% or 20% — and in the UK those are prescription-only medicines, Skinoren and Finacea. You get them from a prescriber.
The evidence at those strengths is genuinely good: in a 24-week trial of 329 women, 20% azelaic acid and 4% hydroquinone produced no statistically significant difference for melasma, and azelaic acid came without hydroquinone’s long-term pigment risk. In a 251-patient rosacea trial, 15% azelaic acid gel beat 0.75% metronidazole gel on lesion count and redness — though it stung noticeably more.
Those results belong to the prescription products. It’s equally wrong to say a cosmetic-strength one “does nothing” — the honest position is that nobody has properly tested it, in either direction. If you want prescription-strength azelaic acid, that’s a conversation with your GP or a pharmacy prescriber, and we’d rather tell you that than pretend otherwise.
Myth: “20% Azelaic Acid Derivative means 20% azelaic acid”
It doesn’t. Several popular products marketed on azelaic acid’s reputation contain potassium azeloyl diglycinate or azeloyl glycine instead — water-soluble molecules invented precisely because the parent acid is so hard to dissolve.
They may well be lovely. But there’s no published evidence that either converts back into azelaic acid on skin, so the prescription research doesn’t transfer. One brand sells an “Azelaic Acid Emulsion 10%” and an “Azelaic Acid Derivative Complex 10%” — two near-identically-named products containing two different molecules.
The habit worth building: read the INCI list, not the front of the box. Where the ingredient sits in that list tells you far more than the number on the label.
A note on the spicules, since we now sell some
The Mary&May contains sponge-derived micro spicules — tiny needle-shaped structures that physically exfoliate as you press the cream in. You’ll see spicule products advertised with a figure like “72 times better absorption”.
That figure is real, and it comes from a study on mice, using a different sponge species, measuring a fluorescent dye. And there is no published study anywhere — human, animal or in a dish — pairing spicules with azelaic acid, niacinamide or salicylic acid. So the mechanism is real; the multiplier for the ingredients you’re actually buying has never been measured, and we’re not going to quote you a number that isn’t about this product. We also won’t call it microneedling: real microneedling is a depth-calibrated device used in a clinic, and this is a cream you press in with a fingertip. More on spicules here.
Two things about that product we’d rather say plainly: it isn’t vegan — the spicules come from sponge, and sponges are animals — and it isn’t fragrance-free, as it contains Limonene, some of it arriving naturally with the tea tree.
Who it suits, and who should be careful
Azelaic acid is generally well tolerated, and it’s not a photosensitiser — unlike retinoids and some AHAs. Daily SPF still applies, for pigment reasons.
Approach with care if you have very reactive or barrier-compromised skin, or if you’re already stacking retinoids and acids. Burning and stinging are the most commonly reported side effects at prescription strength, and the Mary&May specifically isn’t suitable for rosacea, active eczema, a compromised barrier, actively inflamed spots or broken skin.
And if flushing or persistent redness is your main concern, it’s worth getting it looked at rather than self-treating — rosacea, seborrhoeic dermatitis and perioral dermatitis all look similar and are managed differently.
Myths and facts, at a glance
| You’ve heard | Actually |
|---|---|
| 10% is the legal limit in UK skincare | False. No concentration cap exists in UK or EU cosmetics law. Claims draw the line, not percentages |
| A cosmetic serum works like the prescription | Unsupported. Nearly all the trial evidence is 15–20%, which is prescription-only here |
| Cosmetic-strength azelaic acid does nothing | Also unsupported. Nobody has tested it properly either way |
| “Azelaic acid derivative” is the same thing | Different molecule. The prescription evidence doesn’t transfer to it |
| It’s only for pigmentation | Four jobs, not one. Blackheads, spots and redness too — redness is where its best evidence sits |
| Azelaic acid makes you sun-sensitive | It doesn’t. It isn’t a photosensitiser. Wear SPF anyway, for pigment reasons |
| Spicules give “72x better absorption” | Not for you. Mice, a different sponge species, a fluorescent dye. No study pairs spicules with azelaic acid |
| Higher niacinamide percentages always work better | Not established. The pigmentation evidence sits at 4–5% |
Not sure which one is yours? Take our free skin assessment and we’ll tell you your skin type, your priorities and the ingredients that suit your skin, not what’s trending.
This article is general guidance and not medical advice — we are not dermatologists. If you have persistent redness, acne or pigmentation, or you’re pregnant or breastfeeding, please speak to your GP or a pharmacist. Always patch test a new product before applying it to your whole face.
Researched and fact-checked August 2026. Regulatory positions and the state of published evidence can change — the statements above about what has and hasn’t been published are correct as of 23 August 2026.